{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:09:00Z","timestamp":1787580540574,"version":"build-2736575974"},"reference-count":74,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001350","name":"Ministry of Health -Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-000595-01"],"award-info":[{"award-number":["MOH-000595-01"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jceh.2023.06.013","type":"journal-article","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T17:47:02Z","timestamp":1688579222000},"page":"101213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["NAFLD and NAFLD-related HCC in Asia: Burden and Surveillance"],"prefix":"10.1016","volume":"14","author":[{"given":"Jia H.","family":"Koh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2383-5038","authenticated-orcid":false,"given":"Hiroyuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Muthiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8297-1569","authenticated-orcid":false,"given":"Cheng H.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Q.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 2","key":"10.1016\/j.jceh.2023.06.013_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/dom.14521","article-title":"A\u00a0clinical overview of non-alcoholic fatty liver disease: a guide to diagnosis, the clinical features, and complications-What the non-specialist needs to know","volume":"24","author":"Muthiah","year":"2022","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.jceh.2023.06.013_bib2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/cld.81","article-title":"Nonalcoholic fatty liver disease: definitions, risk factors, and workup","volume":"1","author":"Puri","year":"2012","journal-title":"Clin Liver Dis (Hoboken)."},{"key":"10.1016\/j.jceh.2023.06.013_bib3","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/hep.26717","article-title":"Extrahepatic complications of nonalcoholic fatty liver disease","volume":"59","author":"Armstrong","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2023.06.013_bib4","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3350\/cmh.2021.0406","article-title":"Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: an updated meta-analysis with 135,602 individuals","volume":"28","author":"Tang","year":"2022","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jceh.2023.06.013_bib5","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.jhep.2022.07.004","article-title":"Clinical course of non-alcoholic fatty liver disease and the implications for clinical trial design","volume":"77","author":"Allen","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2023.06.013_bib6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12072-022-10319-6","article-title":"Non-alcoholic fatty liver disease association with structural heart, systolic and diastolic dysfunction: a meta-analysis","volume":"16","author":"Yong","year":"2022","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2023.06.013_bib7","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1016\/j.cgh.2021.09.021","article-title":"A\u00a0meta-analysis on the global prevalence, risk factors and screening of coronary heart disease in nonalcoholic fatty liver disease","volume":"20","author":"Toh","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2023.06.013_bib8","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00535-018-1532-5","article-title":"A\u00a0nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011\u20132015 update","volume":"54","author":"Tateishi","year":"2019","journal-title":"J\u00a0Gastroenterol"},{"issue":"suppl 1","key":"10.1016\/j.jceh.2023.06.013_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000333210","article-title":"Relative etiological role of prior hepatitis B virus infection and nonalcoholic fatty liver disease in the development of non-B non-C hepatocellular carcinoma in a hepatitis B-endemic area","volume":"84","author":"Cho","year":"2011","journal-title":"Digestion"},{"key":"10.1016\/j.jceh.2023.06.013_bib10","article-title":"NASH is the leading cause of hepatocellular carcinoma in liver transplant candidates","author":"Koh","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2023.06.013_bib11","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/cld.930","article-title":"NAFLD in lean Asians","volume":"16","author":"Eslam","year":"2020","journal-title":"Clin Liver Dis (Hoboken)."},{"key":"10.1016\/j.jceh.2023.06.013_bib12","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/sj.ijo.0800741","article-title":"Body mass index and percent body fat: a meta analysis among different ethnic groups","volume":"22","author":"Deurenberg","year":"1998","journal-title":"Int J Obes"},{"key":"10.1016\/j.jceh.2023.06.013_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1478-3231.2006.01370.x","article-title":"Hepatitis B: overview of the burden of disease in the Asia-Pacific region","volume":"26","author":"Lesmana","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2023.06.013_bib14","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/apt.17120","article-title":"Universal HBV vaccination dramatically reduces the prevalence of HBV infection and incidence of hepatocellular carcinoma","volume":"56","author":"Wong","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2023.06.013_bib15","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/hepr.13417","article-title":"Epidemiological Research group on viral hepatitis and its long -term course M of HL and W of J. Countermeasures against viral hepatitis B and C in Japan: an epidemiological point of view","volume":"49","author":"Tanaka","year":"2019","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jceh.2023.06.013_bib16","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s13312-014-0520-y","article-title":"Effect of inclusion of hepatitis B vaccine in childhood immunization program in India: a retrospective cohort study","volume":"51","author":"Aggarwal","year":"2014","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.jceh.2023.06.013_bib17","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cmet.2023.02.003","article-title":"The global burden of metabolic disease: data from 2000 to 2019","volume":"35","author":"Chew","year":"2023","journal-title":"Cell Metabol"},{"key":"10.1016\/j.jceh.2023.06.013_bib18","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2023.06.013_bib19","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jhep.2021.05.022","article-title":"Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: data from global burden of disease 2009-2019","volume":"75","author":"Golabi","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2023.06.013_bib20","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/hep.30702","article-title":"Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: a systematic review and meta-analysis","volume":"70","author":"Zhou","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2023.06.013_bib21","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s12072-021-10143-4","article-title":"The epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with individual and forecasting analysis, 1995-2040","volume":"15","author":"Ito","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2023.06.013_bib22","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jceh.2021.11.010","article-title":"Prevalence of non-alcoholic fatty liver disease in India: a systematic review and meta-analysis","volume":"12","author":"Shalimar","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2023.06.013_bib23","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/hepr.13535","article-title":"Modelling the economic and clinical burden of non-alcoholic steatohepatitis in East Asia: data from Hong Kong","volume":"50","author":"Tampi","year":"2020","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jceh.2023.06.013_bib24","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrgastro.2013.34","article-title":"NAFLD in Asia\u2014as common and important as in the West","volume":"10","author":"Farrell","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2023.06.013_bib25","article-title":"Comparative burden of metabolic dysfunction in lean NAFLD vs non-lean NAFLD - a systematic review and meta-analysis","author":"Tang","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2023.06.013_bib26","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/j.1550-8528.1996.tb00245.x","article-title":"Comparisons for body mass index and body fat percent among Puerto Ricans, blacks, whites and Asians living in the New York City area","volume":"4","author":"Wang","year":"1996","journal-title":"Obes Res"},{"key":"10.1016\/j.jceh.2023.06.013_bib27","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/oby.2001.49","article-title":"Larger amounts of visceral adipose tissue in Asian Americans","volume":"9","author":"Park","year":"2001","journal-title":"Obes Res"},{"key":"10.1016\/j.jceh.2023.06.013_bib28","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/apt.12609","article-title":"PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome","volume":"39","author":"Shen","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2023.06.013_bib29","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/hep.24659","article-title":"Genetic variant in PNPLA3 is associated with nonalcoholic fatty liver disease in China","volume":"55","author":"Li","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2023.06.013_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038322","article-title":"Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese","volume":"7","author":"Kawaguchi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2023.06.013_bib31","doi-asserted-by":"crossref","first-page":"316","DOI":"10.5009\/gnl17306","article-title":"Genetic polymorphisms of PNPLA3 and SAMM50 are associated with nonalcoholic fatty liver disease in a Korean population","volume":"12","author":"Chung","year":"2018","journal-title":"Gut Liver"},{"issue":"suppl 1","key":"10.1016\/j.jceh.2023.06.013_bib32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000333210","article-title":"Relative etiological role of prior hepatitis B virus infection and nonalcoholic fatty liver disease in the development of non-B non-C hepatocellular carcinoma in a hepatitis B-endemic area","volume":"84","author":"Cho","year":"2011","journal-title":"Digestion"},{"key":"10.1016\/j.jceh.2023.06.013_bib33","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00535-018-1532-5","article-title":"A\u00a0nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011\u20132015 update","volume":"54","author":"Tateishi","year":"2019","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jceh.2023.06.013_bib34","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030","volume":"69","author":"Estes","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2023.06.013_bib35","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/apt.15673","article-title":"Modelling NAFLD disease burden in four Asian regions-2019-2030","volume":"51","author":"Estes","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2023.06.013_bib36","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jhep.2021.09.024","article-title":"Asian perspective on NAFLD-associated HCC","volume":"76","author":"Yip","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2023.06.013_bib37","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12902-019-0366-3","article-title":"Metabolic syndrome and liver-related events: a systematic review and meta-analysis","volume":"19","author":"Ren","year":"2019","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.jceh.2023.06.013_bib38","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/hep.30858","article-title":"Diabetes is associated with increased risk of hepatocellular carcinoma in patients with cirrhosis from nonalcoholic fatty liver disease","volume":"71","author":"Yang","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2023.06.013_bib39","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12916-019-1321-x","article-title":"Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts","volume":"17","author":"Alexander","year":"2019","journal-title":"BMC Med"},{"key":"10.1016\/j.jceh.2023.06.013_bib40","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/ajg.2011.384","article-title":"Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study","volume":"107","author":"Lai","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2023.06.013_bib41","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/hep.30036","article-title":"Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in nonalcoholic fatty liver disease","volume":"69","author":"Ponziani","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2023.06.013_bib42","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jhep.2014.02.030","article-title":"Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma","volume":"61","author":"Liu","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2023.06.013_bib43","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/ajg.2013.476","article-title":"The effect of PNPLA3 on fibrosis progression and development of hepatocellular carcinoma: a meta-analysis","volume":"109","author":"Singal","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2023.06.013_bib44","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cgh.2011.01.023","article-title":"Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma","volume":"9","author":"Yasui","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2023.06.013_bib45","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1470-2045(22)00078-X","article-title":"Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis","volume":"23","author":"Tan","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jceh.2023.06.013_bib46","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/apt.17165","article-title":"Extrahepatic morbidities and mortality of <scp>NAFLD<\/scp> : an umbrella review of meta-analyses","volume":"56","author":"Yi","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2023.06.013_bib47","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/apt.15673","article-title":"Modelling NAFLD disease burden in four Asian regions-2019-2030","volume":"51","author":"Estes","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2023.06.013_bib48","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American association for the study of liver diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2023.06.013_bib49","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.14309\/ajg.0000000000000715","article-title":"Cost-effectiveness of hepatocellular carcinoma surveillance: an assessment of benefits and harms","volume":"115","author":"Parikh","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2023.06.013_bib50","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.cgh.2021.05.002","article-title":"Incidence of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression","volume":"20","author":"Orci","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2023.06.013_bib51","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1053\/j.gastro.2019.12.053","article-title":"AGA clinical practice update on screening and surveillance for hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: expert review","volume":"158","author":"Loomba","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2023.06.013_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-016-9760-3","article-title":"Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update","volume":"11","author":"Shiha","year":"2017","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2023.06.013_bib53","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","author":"Singal","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2023.06.013_bib54","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jhep.2019.08.025","article-title":"Epidemiology and surveillance for hepatocellular carcinoma: new trends","volume":"72","author":"Singal","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2023.06.013_bib55","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.cgh.2021.06.012","article-title":"Dynamic changes in ultrasound quality for hepatocellular carcinoma screening in patients with cirrhosis","volume":"20","author":"Schoenberger","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2023.06.013_bib56","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1053\/j.gastro.2018.01.064","article-title":"Surveillance imaging and alpha fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis","volume":"154","author":"Tzartzeva","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2023.06.013_bib57","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/apt.13841","article-title":"Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis","volume":"45","author":"Simmons","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2023.06.013_bib58","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/lt.25202","article-title":"Predictors of ultrasound failure to detect hepatocellular carcinoma","volume":"24","author":"Samoylova","year":"2018","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2023.06.013_bib59","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1111\/liv.15110","article-title":"Abbreviated magnetic resonance imaging vs ultrasound for surveillance of hepatocellular carcinoma in high-risk patients","volume":"42","author":"Park","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2023.06.013_bib60","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.jceh.2023.06.013_bib61","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1148\/radiol.2402051110","article-title":"Effect of obesity on image quality: fifteen-year longitudinal study for evaluation of dictated radiology reports","volume":"240","author":"Uppot","year":"2006","journal-title":"Radiology"},{"key":"10.1016\/j.jceh.2023.06.013_bib62","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00261-017-1317-y","article-title":"American College of Radiology Ultrasound Liver Imaging and Reporting Data System (US LI-RADS) Working Group. US LI-RADS: ultrasound liver imaging reporting and data system for screening and surveillance of hepatocellular carcinoma","volume":"43","author":"Morgan","year":"2018","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.jceh.2023.06.013_bib63","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1001\/jamaoncol.2016.3147","article-title":"MRI with liver-specific contrast for surveillance of patients with cirrhosis at high risk of hepatocellular carcinoma","volume":"3","author":"Kim","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jceh.2023.06.013_bib64","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/RLI.0000000000000273","article-title":"Safety of the gadolinium-based contrast agents for magnetic resonance imaging, focusing in part on their accumulation in the brain and especially the dentate nucleus","volume":"51","author":"Runge","year":"2016","journal-title":"Invest Radiol"},{"key":"10.1016\/j.jceh.2023.06.013_bib65","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jhep.2021.01.041","article-title":"Abbreviated MRI for hepatocellular carcinoma screening: a systematic review and meta-analysis","volume":"75","author":"Gupta","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2023.06.013_bib66","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/apt.16844","article-title":"Comparative efficacy of an optimal exam between ultrasound versus abbreviated MRI for HCC screening in NAFLD cirrhosis: a prospective study","volume":"55","author":"Huang","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2023.06.013_bib67","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4254\/wjh.v7.i2.139","article-title":"Current biomarkers for hepatocellular carcinoma: surveillance, diagnosis and prediction of prognosis","volume":"7","author":"Sch\u00fctte","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jceh.2023.06.013_bib68","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/bjc.2014.536","article-title":"A\u00a0new approach to the use of \u03b1-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis","volume":"112","author":"Biselli","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jceh.2023.06.013_bib69","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jhep.2005.03.019","article-title":"Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial","volume":"43","author":"Di Bisceglie","year":"2005","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2023.06.013_bib70","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/j.gastro.2009.04.005","article-title":"Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma","volume":"137","author":"Marrero","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2023.06.013_bib71","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1053\/j.gastro.2009.10.031","article-title":"Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma","volume":"138","author":"Lok","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2023.06.013_bib72","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0016-5085(03)00689-9","article-title":"Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma","volume":"125","author":"Capurro","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2023.06.013_bib73","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.cgh.2019.11.012","article-title":"GALAD score detects early hepatocellular carcinoma in an international cohort of patients with nonalcoholic steatohepatitis","volume":"18","author":"Best","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2023.06.013_bib74","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1053\/j.gastro.2021.01.233","article-title":"International liver cancer association (ILCA) white paper on biomarker development for hepatocellular carcinoma","volume":"160","author":"Singal","year":"2021","journal-title":"Gastroenterology"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S097368832300138X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S097368832300138X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:10:34Z","timestamp":1760854234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S097368832300138X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S097368832300138X"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2023.06.013","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NAFLD and NAFLD-related HCC in Asia: Burden and Surveillance","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2023.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101213"}}